Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03590028 · ClinicalTrials.gov registry record · NA

An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury

A NA study of Acute Kidney Injury, sponsored by University of Chicago.

Active
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT03590028 is a NA study of Acute Kidney Injury that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 180 participants, below the 2,329-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03590028, a NA study of Acute Kidney Injury, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This is a single center randomized trial that seeks to determine if the use of an automated real-time electronic medical record Acute Kidney Injury (AKI) risk score can improve patient outcomes through the use of an early standardized nephrology focused intervention.

Conditions Studied

Interventions

  • OTHER Standard of Care (SOC)
  • OTHER Early Nephrology Consult (ENC)

Study Locations (1)

Illinois

  • University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2018-10-01
Est. Completion 2026-01-31
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT03590028

The ClinicalTrials.gov registry entry for NCT03590028 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,329-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (92% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care (SOC) is the first listed.

NCT03590028 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03590028 about?

NCT03590028 is a clinical study titled "An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury". This is a single center randomized trial that seeks to determine if the use of an automated real-time electronic medical record Acute Kidney Injury (AKI) risk score can improve patient outcomes through the use of an early standardized nephrology focused intervention.

What is the current status of trial NCT03590028?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2018-10-01. Estimated completion is 2026-01-31.

What conditions does trial NCT03590028 study?

This clinical trial studies the following conditions: Acute Kidney Injury.

What interventions are being tested in trial NCT03590028?

The interventions under investigation include: Standard of Care (SOC) (OTHER), Early Nephrology Consult (ENC) (OTHER).

Who is sponsoring clinical trial NCT03590028?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03590028 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Kidney Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.